BioSpace News Archive

FDA

Lynparza Becomes Second PARP Inhibitor Approved for Prostate Cancer, Just Days Behind the First

Clovis Oncology’s Rubraca remained the only PARP inhibitor approved for prostate cancer for only a handful of days. Today, that medication is joined by AstraZeneca’s and Merck’s powerhouse PARP inhibitor, Lynparza.

May 20, 2020
·
3 min read
·
Alex Keown
Business

Critics Target Moderna’s Interim COVID-19 Vaccine Data

The company reported overall positive results for both efficacy and safety, although not a lot of details were released on the actual data.

May 20, 2020
·
3 min read
·
Mark Terry
Drug Development

Atea Pharma to Launch Phase II Trial Against COVID-19 After Raising $215 Million Series D

In addition to the COVID-19 development, the company plans to use the proceeds toward its pipeline of highly selective direct acting antivirals that target other severe RNA virus infections.

May 20, 2020
·
3 min read
·
Mark Terry
BioSpace Global Roundup, May 21

Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.

May 20, 2020
·
6 min read
·
Alex Keown
Policy

Biopharma Update on the Novel Coronavirus: May 20

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 20, 2020.

May 20, 2020
·
6 min read
·
BioSpace Editorial Staff
Preparing to Return to Work During a Pandemic

As COVID-19 stay-at-home restrictions begin to lift and pressure mounts to “reopen” the United States, workers will increasingly be asked to return to the workplace.

May 20, 2020
·
4 min read
·
Katharine Hansen, PhD
Deals

To Secure Manufacturing Needs, eGenesis Buys ICBiotec to Support Gene-Edited Organ Transplant Capabilities

Xenotransplant company eGenesis snapped up a key manufacturing partner ICBiotec in order to vertically integrate its xeno-organ production capabilities.

May 20, 2020
·
2 min read
·
Alex Keown
Business

Mammoth Strikes Deal with GSK Consumer Healthcare to Develop COVID-19 Test Using CRISPR-Based Platform

Weeks after Mammoth Biosciences announced its CRISPR-based diagnostics test for COVID-19 had a high degree of specificity even for asymptomatic patients, the company has struck a deal with GSK to accelerate development of the test in hopes of getting them in consumer hands as soon as possible.

May 20, 2020
·
3 min read
·
Alex Keown
Breakthrough in Stem Cell Research Shows Promise for Treating Multiple Sclerosis

A research study in mice by investigators at the University of Rochester Medical Center suggests it would be possible to repair the brain cell damage caused by multiple sclerosis.

May 20, 2020
·
3 min read
·
Mark Terry
Business

Ease of Use, Higher Efficacy Drive Lilly’s New Diabetes Treatments

Diabetes and obesity remain a problem, even during a pandemic. Eli Lilly is continuing to develop the 13 diabetes drugs it has in Phase I through Phase III trials, with data from various trials planned for release throughout the coming year.

May 20, 2020
·
4 min read
·
Gail Dutton